Alaunos Therapeutics Inc (NASDAQ:TCRT)

1.76
Delayed Data
As of Aug 11
 -0.08 / -4.30%
Today’s Change
0.41
Today|||52-Week Range
2.43
+61.47%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Alaunos Therapeutics Inc have a median target of 3.00, with a high estimate of 7.50 and a low estimate of 1.50. The median estimate represents a +70.45% increase from the last price of 1.76.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Alaunos Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.05
Sales
$0.00
Reporting Date
Aug 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.00%
 
 
 
 
 
 
Growthannually 40.99%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually -100.00%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.